CRISPR is a highly effective immune system that defends bacteria from viruses. It was recently shown that some viruses have evolved counter-defenses that protect their DNA with a nucleus-like structure. Continue reading Some viruses can defeat CRISPR with nucleus-like compartments
CRISPR genome editing has been used to study the biology of a number of species, but its use in reptiles has been difficult to achieve. Scientists have now figured this out, and albino lizards are the product! Read Ben Andreone’s article to learn more! Continue reading Albino Lizards are the First Ever Genome Edited Reptiles
Cancer immunotherapy exploits our immune system to kill cancerous cells. Recently, researchers have discovered a novel way to do this. They engineered cells that are programmed to die and injected them into tumor. They have successfully shown that the dying cells is able to kill tumor cells via recruitment of the immune system. This strategy might be a potential new method to improve the efficacy of current cancer immunotherapy methods. Continue reading The New Trojan Horse: Using tumor cells to kill tumors
by Valentina Lagomarsino figures by Sean Wilson Nearly four months ago, Chinese researcher He Jiankui announced that he had edited the genes of twin babies with CRISPR. CRISPR, also known as CRISPR/Cas9, can be thought of as “genetic scissors” that can be programmed to edit DNA in any cell. Last year, scientists used CRISPR to cure dogs of Duchenne muscular dystrophy. This was a huge step forward for … Continue reading Arrival of Gene-Edited Babies: What lies ahead?
by Michael Vinyard figures by Nicholas Lue Most therapeutic drug candidates that are put through clinical trials fail. Given that most of these fail during early development, the cost of bringing a single drug to market is now over $2.5 billion. If we focus on cancer alone, this high cost of drug development, combined with the fact that cancer is one of the leading killers in … Continue reading CRISPR-Scanning Towards New Drugs — drug discovery is difficult, but CRISPR might be able to help
While you are likely familiar with the annoying experience of being a mosquito’s ‘meal of the day’, more is going on behind the scenes of that insect bite than meets the eye. Mosquitoes, which are drawn to human scent and breath, require proteins from the blood of their victims to develop their eggs and reproduce. This sounds harmless enough, but mosquitoes also excel at picking … Continue reading New Drug May Prevent Mosquitoes From Wanting to Bite You
In December 2018, a Chinese researcher, He Jiankui, shocked the world when he revealed the birth of the world’s first genetically edited babies. While it is clear that Jiankui egregiously violated university regulations and ethical standards, his announcement has since ignited a heated international dialogue about the permissibility of human embryonic gene editing. Currently, there are scientists in the United States working in university laboratories, … Continue reading Genetic editing of human embryos in the United States ignites debate
A Chinese researcher, He Jiankui, shocked the world two weeks ago when he revealed that the world’s first genetically edited babies had been born. Jiankui claimed to have edited embryos before implanting them into the mother as part of an otherwise routine in vitro fertilization (IVF) procedure. Since his bold announcement via YouTube, the scientific community at-large – both in the United States and in … Continue reading China’s Genetically Edited babies: What really happened?
In an exciting step forward, dogs with Duchenne muscular dystrophy (DMD) were treated with the CRISPR genome editor to restore production of the missing protein responsible for the disease. After more studies to prove it is safe and effective long-term, this has the potential to move into clinical trials as a DMD therapy. “[The dogs] showed obvious signs of behavioral improvement – running, jumping – … Continue reading Dogs with muscular dystrophy receive CRISPR treatment: What does this mean for humans?
by Jessalyn Ubellacker figure by Jovana Andrejevic Between September 1999 and June 2000, the first human genome was sequenced. Since then, scientists have learned not only to read the human genome, but also to manipulate it, offering unprecedented opportunities to improve human health through genetic alterations. One example of this is gene drive technology, which circumvents classical inheritance patterns to ‘drive’ the presence of particular … Continue reading Buckle Up for Gene Drives of the Future!